Fractures, Bone: Clinical Trials

17 trials for Fractures, Bone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 terminated. 17 Phase 2, 5 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 217Terminated 17
Phase 35Terminated 5
Phase 13Terminated 3

Follow Fractures, Bone: new trials by email Literature Review of Fractures, Bone trials Research Report on Fractures, Bone

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bone in CKD Alkali Response (BICARb Pilot Trial)
Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss
Phase 2 / Phase 3TerminatedAlbert Einstein College of Medicine62024-08-152026-07-28
PTH Analog Type II Odontoid Fracture
Abaloparatide, Hard collar immobilization - Odontoid Fracture
Phase 2TerminatedDavid Lunardini222022-05-182024-09-19
Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures
Liposomal Bupivacaine, Ropivacaine HCL - Femoral Fractures
Phase 2TerminatedIan Elliott Brown32017-10-012021-02-21
A Pilot Study of TRV130 for the Treatment of Fracture Pain
TRV130 - Pain
Phase 2TerminatedTrevena Inc.12015-10-202020-09-07
Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion
ALLOBĀ® - Failed Lumbar Fusion
Phase 2TerminatedBone Therapeutics S.A62014-09-012020-06-11
A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures
Amorphous calcium carbonate, Placebo - Distal Radius Fractures
Phase 1 / Phase 2TerminatedAmorphical Ltd.152013-06-012016-08-04
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures
ICG (Indocyanine Green) - Fractures, Comminuted, Surgical Wound Dehiscence
Phase 2 / Phase 3TerminatedLouisiana State University Health Sciences Center Shreveport132013-04-012017-06-20
Study on Autologous Osteoblastic Cells Implantation in Hypotrophic Non-Union Fractures
PREOBĀ® Implantation, Bone Autograft - Long Bone Non-Union
Phase 2 / Phase 3TerminatedBone Therapeutics S.A52012-06-012020-06-11
Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts
Cellularized composite graft augmentation, Acellular composite graft augmentation - Osteoporotic Fractures
Phase 2TerminatedUniversity Hospital, Basel, Switzerland82012-06-012014-09-17
A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius
SB-751689, Placebo - Fracture Healing
Phase 2TerminatedGlaxoSmithKline862007-09-202017-04-12
A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures
rhBMP-2/CPM - Fractures
Phase 2 / Phase 3TerminatedWyeth is now a wholly owned subsidiary of Pfizer3672006-11-012013-02-28
Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)
MK0677 - Hip Fracture
Phase 2TerminatedMerck Sharp & Dohme LLC832005-09-012016-01-20
A Study to Evaluate the Safety and Effectiveness of Different Doses of Chrysalin in Adults Who Have a Broken Wrist
Chrysalin, Placebo - Radius Fracture
Phase 2TerminatedCapstone Therapeutics2742004-11-012010-08-24
Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.
Fracture surgery, Cultured Bone Marrow Tissue - Fracture, Ununited, Pseudarthrosis
Phase 1 / Phase 2TerminatedVericel Corporation362003-10-012021-05-11
Image Guided System for Orthopaedic Surgery
Image-guided surgical system - Orthopaedic Trauma, Hip Fracture
Phase 2TerminatedNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)402002-12-012009-04-09
Stress Response Using Thin and Standard Size Endoscopy.
transnasal endoscopy, transoral thin endoscopy - Upper Gastrointestinal Disease,Ulcers
Phase 2 / Phase 3TerminatedHvidovre University Hospital601999-03-012006-09-13
New Method for Distal Interlocking of Cannulated Intramedullary Nails
The Guiding Star, fluoroscopy (OEC 9800 - General Electric) - Fracture
Phase 1 / Phase 2TerminatedHadassah Medical Organization102011-12-28

Narrower conditions

Hip Fractures (3)  ·  Pseudarthrosis (2)  ·  Wrist Fractures (2)  ·  Acidosis (1)  ·  Bone Diseases, Metabolic (1)  ·  Femoral Fractures (1)  ·  Fractures, Comminuted (1)  ·  Fractures, Stress (1)  ·  Fractures, Ununited (1)  ·  Gastrointestinal Diseases (1)  ·  Ischemia (1)  ·  Musculoskeletal Diseases (1)  ·  Necrosis (1)  ·  Osteoporosis (1)

Broader conditions

Wounds and Injuries (16)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Arm Injuries (3)  ·  Hip Injuries (3)  ·  Leg Injuries (3)  ·  Pathologic Processes (3)  ·  Bone Diseases (2)  ·  Femoral Fractures (2)  ·  Metabolic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Wrist Injuries (2)  ·  Acid-Base Imbalance (1)  ·  Bone Diseases, Metabolic (1)

Interventions

((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1)  ·  Citric Acid (1)  ·  Fibrin Tissue Adhesive (1)  ·  Fluoroscopy (1)  ·  Indocyanine Green (1)  ·  Potassium Citrate (1)  ·  Ropivacaine (1)  ·  abaloparatide (1)  ·  ibutamoren mesylate (1)  ·  rusalatide acetate (1)

Sponsors

Bone Therapeutics S.A (2)  ·  Albert Einstein College of Medicine (1)  ·  Amorphical Ltd. (1)  ·  Capstone Therapeutics (1)  ·  David Lunardini (1)  ·  GlaxoSmithKline (1)  ·  Hadassah Medical Organization (1)  ·  Hvidovre University Hospital (1)  ·  Ian Elliott Brown (1)  ·  Louisiana State University Health Sciences Center Shreveport (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)  ·  Trevena Inc. (1)  ·  University Hospital, Basel, Switzerland (1)  ·  Vericel Corporation (1)

Countries

United States (9)  ·  Spain (3)  ·  Sweden (3)  ·  United Kingdom (3)  ·  Argentina (2)  ·  Australia (2)  ·  Belgium (2)  ·  France (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Romania (2)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)

Top investigators

David Lunardini, MD (1)  ·  Einat Dekel, DVM (1)  ·  Franziska Saxer, MD (1)  ·  Ian Brown, MD (1)  ·  James Goulet, MD (1)  ·  James Ryaby, Ph.D. (1)  ·  Kimberly Reidy, MD (1)  ·  Marcel Jakob, MD (1)  ·  Matthew Jimenez, MD (1)  ·  Merete Christensen, MD (1)  ·  Omri Lubovsky, MD (1)

Results publications

PMID 21067829, PMID 21742071, PMID 35727196, PMID 39665575

NIH funding

2023 (1), R01DK131811 (1)